Zoonotic & Vector-Borne Diseases

Highest amounts of Toxocara egg contamination were in areas that could contain food droppings or animal waste.

Sanofi Pasteur’s dengue vaccine (Dengvaxia) is moving one step closer to being approved in the United States as the FDA just accepted a Biologics License Application for the vaccine.

The proliferation of malaria-specific cord blood CD4+ T cells is associated with protection from childhood malaria.

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).

The virus may be fading from mainstream headlines, but it is active and physicians must stay vigilant.

From August 2014 to September 2018, the CDC received information on a total of 386 confirmed US cases of a polio-like illness occurring mostly among children.

The inactivated recombinant vaccine protected guinea pigs that were exposed to the Lassa virus 58 days post-vaccination.

New report highlights potential for direct testing of the tick-borne disease.

The Government of India Ministry of Health and Family Welfare has announced 22 confirmed cases of Zika virus in Jaipur as of October 8, 2018.

Kenneth E. Sherman, MD discusses the zoonotic hepatitis E virus and about the first reported case of rat-to-human transmission.

Los Angeles County Department of Public Health is investigating an influx of cases of flea-borne typhus in downtown Los Angeles.

The new vaccine schedule is 7 days between doses for adults aged 18 to 65, instead of the standard 28 days.

In September 2017, a patient in Hong Kong was diagnosed with rat hepatitis E virus after inflammation of the liver was observed.

During a multidrug-resistant Campylobacter outbreak, 142 puppies were identified as receiving 1 or more antibiotic courses before arriving or while at the store.

Investigators have developed an innovative method to identify molecules capable of eliminating the Leishmania parasite.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Ebola is not the only infectious disease that health officials in the Democratic Republic of the Congo are struggling with.

Tick-borne infections will pose significant threats in the near future, according to infectious disease experts.

The National Emerging Infectious Disease Laboratories at Boston University have the latest equipment, security redundancies, and airtight procedures and protocols. Yet, as they begin work on Ebola and Marburg, they cannot eliminate the risk of human error.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The FDA has added Lassa fever, chikungunya virus disease, rabies, and cryptococcal meningitis to the tropical disease Priority Review Voucher Program.

Health care providers, especially those practicing in the southern United States, should consider angiostrongyliasis in patients with eosinophilic meningitis.

A recent molecular study has confirmed the causative agent involved in a large epidemic of Rocky Mountain spotted fever in humans and dogs in Mexicali, in Baja California, Mexico.

A new report from researchers at the Centers for Disease Control and Prevention details the investigational use of a drug to treat Chagas disease now available commercially in the United States.

The CDC now recommends that men who have been exposed to Zika use condoms or abstain from sex for 3 months to prevent sexual transmission of Zika.

A species of tick that is native to Australia, New Zealand, and eastern Asia, has been springing up in several US states this summer.

The FDA approves tafenoquine tablets for the prevention of malaria in patients aged 18 and older.

Researchers in Slovenia investigate why some Lyme disease patients respond more quickly to treatment than others.

Investigators from Yale School of Medicine, in collaboration with Novartis Vaccines, Inc, have developed a novel vaccine that successfully protects against malaria infection in a mouse model.

Tafenoquine is the first single-dose medicine for the prevention of P vivax malaria relapse.